UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge

Annals of oncology, 2019-02, Vol.30 (2), p.243-249

2019

Volltextzugriff (PDF)

Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients

Annals of oncology, 2018-04, Vol.29 (4), p.1037-1048

2018

Volltextzugriff (PDF)

Integration of Force Reflection with Tactile Sensing for Minimally Invasive Robotics-Assisted Tumor Localization

IEEE transactions on haptics, 2013-04, Vol.6 (2), p.217-228

2013

Volltextzugriff (PDF)

Serial assessment of cell-free circulating tumor DNA (ctDNA) to assess treatment effect and minimal residual disease during neoadjuvant and adjuvant therapy in colorectal cancer

Annals of oncology, 2019-07, Vol.30, p.iv131-iv131

2019

Volltextzugriff (PDF)

The effect of a single dose of vitamin D on glycemic status and C-reactive protein levels in type 2 diabetic patients with ischemic heart disease: a randomized clinical trial

Acta diabetologica, 2016-08, Vol.53 (4), p.575-582

2016

Volltextzugriff (PDF)

Circulating cell-free DNA profiling of patients with advanced urothelial carcinoma

European journal of cancer (1990), 2016-06, Vol.60, p.e5-e5

2016

Volltextzugriff (PDF)

Development and analytical validation of a plasma-based tumor mutational burden (TMB) score from next-generation sequencing panels

Annals of oncology, 2018-10, Vol.29, p.viii41-viii41

2018

Volltextzugriff (PDF)

Microsatellite instability detection by targeted sequencing of cell-free DNA

Annals of oncology, 2018-10, Vol.29, p.viii424-viii424

2018

Volltextzugriff (PDF)

462 Clinical sequencing of cancer in real-time by digital sequencing of cell-free DNA for tailoring targeted therapy in refractory cancer patients

European journal of cancer (1990), 2014-11, Vol.50, p.151-151

2014

Volltextzugriff (PDF)

Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial

BMJ (Online), 2022-01, Vol.376, p.e068407

INSPIRATION-S Investigators

2022

Volltextzugriff (PDF)

Electrical detection of protein biomarkers using bioactivated microfluidic channels

Lab on a chip, 2009-05, Vol.9 (10), p.1429-1434

2009

Volltextzugriff (PDF)

451 Correlative and updated clinical endpoint analysis of a multicenter phase II trial of selumetinib (AZD6244) plus erlotinib in chemotherapy-refractory advanced pancreatic adenocarcinoma (PDAC)

European journal of cancer (1990), 2014-11, Vol.50, p.148-148

2014

Volltextzugriff (PDF)

P4611Colchicine before percutaneous coronary intervention in acute myocardial infarction

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

Variable Structure Control with Adaptive Fuzzy Sliding Surface

Journal of vibration and control, 2006-11, Vol.12 (11), p.1251-1270

2006

Volltextzugriff (PDF)

P1648Potential role of vitamin C intracoronary administration in preventing cardiac injury after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction

European heart journal, 2018-08, Vol.39 (suppl_1)

2018

Volltextzugriff (PDF)

Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation on functional outcomes

European journal of internal medicine, 2022-09, Vol.103, p.76-83

2022

Volltextzugriff (PDF)

A Microfluidic Platform for Characterization of Protein-Protein Interactions

IEEE sensors journal, 2009-08, Vol.9 (8), p.883-891

2009

Volltextzugriff (PDF)

Steroid use for recovery of advanced atrioventricular block immediately after valvular surgery (survival): a randomized clinical trial

Europace (London, England), 2021-05, Vol.23 (Supplement_3)

2021

Volltextzugriff (PDF)

Differential response to interleukin-1 blockade with anakinra on cardiorespiratory fitness in patients with heart failure with preserved ejection fraction stratified according to ejection fraction

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

419P Minimal residual disease (MRD) detection in colorectal cancer (CRC) using a plasma-only integrated genomic and epigenomic circulating tumor DNA (ctDNA) assay

Annals of oncology, 2020-09, Vol.31, p.S419-S419

2020

Volltextzugriff (PDF)

O-016Serial assessment of cell-free circulating tumor DNA (ctDNA) to assess treatment effect and minimal residual disease during neoadjuvant and adjuvant therapy in colorectal cancer

Annals of oncology, 2019-07, Vol.30 (Supplement_4)

2019

Volltextzugriff (PDF)

FP05.03 Multiomic, Plasma-Only ctDNA NGS Assay Developed for Minimal Residual Disease (MRD) Detection in Early-Stage NSCLC

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S952-S953

2021

Volltextzugriff (PDF)

Tribulus terrestris-induced severe nephrotoxicity in a young healthy male

Nephrology, dialysis, transplantation, 2010-11, Vol.25 (11), p.3792-3793

2010

Volltextzugriff (PDF)

131PDevelopment and analytical validation of a plasma-based tumor mutational burden (TMB) score from next-generation sequencing panels

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Abstract P3-05-02: Detection of activating estrogen receptor 1 (ESR1) in circulating tumor DNA (ctDNA) in hormone-receptor positive metastatic breast cancer (MBC)

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P3-P3-05-02

2016

Volltextzugriff (PDF)

1 – 25 von 394

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(344)
Mit Volltextzugriff
(337)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge

Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients

Integration of Force Reflection with Tactile Sensing for Minimally Invasive Robotics-Assisted Tumor Localization

Serial assessment of cell-free circulating tumor DNA (ctDNA) to assess treatment effect and minimal residual disease during neoadjuvant and adjuvant therapy in colorectal cancer

The effect of a single dose of vitamin D on glycemic status and C-reactive protein levels in type 2 diabetic patients with ischemic heart disease: a randomized clinical trial

Circulating cell-free DNA profiling of patients with advanced urothelial carcinoma

Development and analytical validation of a plasma-based tumor mutational burden (TMB) score from next-generation sequencing panels

Microsatellite instability detection by targeted sequencing of cell-free DNA

462 Clinical sequencing of cancer in real-time by digital sequencing of cell-free DNA for tailoring targeted therapy in refractory cancer patients

Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial

Electrical detection of protein biomarkers using bioactivated microfluidic channels

451 Correlative and updated clinical endpoint analysis of a multicenter phase II trial of selumetinib (AZD6244) plus erlotinib in chemotherapy-refractory advanced pancreatic adenocarcinoma (PDAC)

P4611Colchicine before percutaneous coronary intervention in acute myocardial infarction

Variable Structure Control with Adaptive Fuzzy Sliding Surface

P1648Potential role of vitamin C intracoronary administration in preventing cardiac injury after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction

Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation on functional outcomes

A Microfluidic Platform for Characterization of Protein-Protein Interactions

Steroid use for recovery of advanced atrioventricular block immediately after valvular surgery (survival): a randomized clinical trial

Differential response to interleukin-1 blockade with anakinra on cardiorespiratory fitness in patients with heart failure with preserved ejection fraction stratified according to ejection fraction

419P Minimal residual disease (MRD) detection in colorectal cancer (CRC) using a plasma-only integrated genomic and epigenomic circulating tumor DNA (ctDNA) assay

O-016Serial assessment of cell-free circulating tumor DNA (ctDNA) to assess treatment effect and minimal residual disease during neoadjuvant and adjuvant therapy in colorectal cancer

FP05.03 Multiomic, Plasma-Only ctDNA NGS Assay Developed for Minimal Residual Disease (MRD) Detection in Early-Stage NSCLC

Tribulus terrestris-induced severe nephrotoxicity in a young healthy male

131PDevelopment and analytical validation of a plasma-based tumor mutational burden (TMB) score from next-generation sequencing panels

Abstract P3-05-02: Detection of activating estrogen receptor 1 (ESR1) in circulating tumor DNA (ctDNA) in hormone-receptor positive metastatic breast cancer (MBC)

Suchergebnisse filtern